bioMérieux
(OTC) BMXMF
bioMérieux Financials at a Glance
Market Cap
$12.44B
Revenue (TTM)
$8.05B
Net Income (TTM)
$829.41M
EPS (TTM)
$3.80
P/E Ratio
27.54
Dividend
$1.03
Beta (Volatility)
0.27 (Low)
Dividend
$1.03
Beta (Volatility)
0.27 (Low)
Price
$105.41
Volume
1
Open
$105.41
Price
$105.41
Volume
1
Open
$105.41
Previous Close
$105.41
Daily Range
$105.41 - $105.41
52-Week Range
$102.25 - $152.00
Dividend
$1.03
Beta (Volatility)
0.27 (Low)
Price
$105.41
Volume
1
Open
$105.41
Previous Close
$105.41
Daily Range
$105.41 - $105.41
52-Week Range
$102.25 - $152.00
BMXMF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout bioMérieux
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
15,078
CEO
Pierre Boulud
Website
www.biomerieux.comHeadquarters
Marcy l'Étoile, 69280, FR
BMXMF Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
10%
Net Income Margin
10%
Return on Equity
10%
Return on Capital
9%
Return on Assets
7%
Earnings Yield
3.63%
Dividend Yield
0.01%
Payout Ratio
26.71%
Stock Overview
Market Cap
$12.44B
Shares Outstanding
117.99M
Volume
1
Short Interest
0.00%
Avg. Volume
56.016
Financials (TTM)
Gross Profit
$2.14B
Operating Income
$560.99M
EBITDA
$999.23M
Operating Cash Flow
$788.00M
Capital Expenditure
$335.17M
Free Cash Flow
$452.83M
Cash & ST Invst.
$569.59M
Total Debt
$461.23M
bioMérieux Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.03B
+6.3%
Gross Profit
$992.43M
+2.2%
Gross Margin
49.00%
N/A
Market Cap
$12.44B
N/A
Market Cap/Employee
$879.13K
N/A
Employees
14,147
N/A
Net Income
$236.21M
+20.5%
EBITDA
$475.72M
-0.5%
Quarterly Fundamentals
Net Cash
$108.36M
+165.1%
Accounts Receivable
$1.01B
+38.7%
Inventory
$959.34M
+5.6%
Long Term Debt
$329.88M
-7.2%
Short Term Debt
$131.35M
-19.6%
Return on Assets
7.13%
N/A
Return on Invested Capital
8.61%
N/A
Free Cash Flow
$288.09M
+163.1%
Operating Cash Flow
$470.62M
+58.2%